미국의 심장질환 치료기 전문업체인 스펙트라네틱스 (Spectranetics Corp.)는 1984년에 설립된 글로벌 기업입니다.
더 나은 삶과 모두를 위한 세상을 향한 그들의 목표에 필요한 연구를 위해 Esco Horizontal laminar flow cabinet을 선택하였습니다.
The Spectranetics Corp. is a US-based global leader in vascular intervention and lead management solution that was founded in 1984. Their technologies are used mainly by physicians to complete medical procedures which includes catheters and drug-coated balloon that provides proven coronary and peripheral artery disease. Currently, The Spectranetics is growing with over 900 employees.
On 09 August 2017, The Spectranetics was officially merged with Royal Philips – also a global leader in health technology. It is expected for this strategic expansion to deliver a wider range of highly competitive therapy devices, interventional imaging systems, software and service which will lead to more enhanced care for patients by enabling clinicians to decide, guide, treat and confirm the appropriate cardiac and peripheral vascular treatment.
Together, their initiative goal is to create a better life and a better world for everyone. To meet their goal, it is essential for them to have an effective and reliable equipment.
To achieve this goal, they chose Esco horizontal laminar flow cabinets to assemble and inspect cardiac and peripheral vascular devices. The cleaner ISO Class 3 work zone created by ULPA filter with 99.999% efficiency that comes standard in Esco Laminar Flow cabinets compared to HEPA filter with 99.99% efficiency on other cabinets, improves the cleanliness of these critical medical equipment that will be inserted to human blood stream. Contamination prevention is critical for this application to prevent pathogens to go direct into the patient heart and blood stream. Esco higher filter efficiency helps to add this additional layer of safety into this contamination critical application.